Drug Comparison

Ozempic vs. Wegovy vs. Mounjaro vs. Rybelsus

A complete side-by-side comparison of all major GLP-1 weight loss medications available in Canada - efficacy, cost, dosing, and coverage.

Updated May 20264 medications comparedCanadian pricing

Medication Profiles

O

Ozempic

semaglutide · Novo Nordisk

FormInjectable (pen)
FrequencyOnce weekly
Weight loss~9–13%
Monthly cost$200–$450/mo
Public coverageFor T2D (LU code)
  • Most commonly prescribed GLP-1 in Canada
  • Widely prescribed off-label for weight management
  • Weekly auto-inject pen
  • Generic versions now approved (2025)
  • Covered by most provincial plans for T2D
Full Ozempic guide →
W

Wegovy

semaglutide 2.4 mg · Novo Nordisk

FormInjectable (pen)
FrequencyOnce weekly
Weight loss~15%
Monthly cost$385–$430/mo
Public coverageNot listed for weight mgmt
  • Specifically approved for weight management (BMI ≥30 or ≥27 + comorbidity)
  • Higher dose than Ozempic - greater weight loss
  • 16–20 week titration to maintenance dose
  • Home delivery at no extra cost via Care Rx
  • Not covered provincially for weight management alone
Full Wegovy guide →
M

Mounjaro

tirzepatide · Eli Lilly

FormInjectable (autoinjector)
FrequencyOnce weekly
Weight loss~15–21%
Monthly cost$400–$620+/mo
Public coverageLimited - T2D with auth.
  • Dual GIP + GLP-1 receptor agonist (unique mechanism)
  • Greatest average weight loss of any approved GLP-1
  • ~47% of patients lose ≥20% body weight (SURMOUNT-1, 15 mg)
  • Not yet separately approved for weight management in Canada
  • Highest price of the class; no generics yet
Full Mounjaro guide →
R

Rybelsus

oral semaglutide · Novo Nordisk

FormOral tablet
FrequencyOnce daily
Weight loss~4–5%
Monthly cost$200–$350/mo
Public coverageFor T2D in several provinces
  • World's first approved oral GLP-1 receptor agonist
  • No needles - daily tablet
  • Must be taken fasted, with ≤120 mL plain water, 30 min before eating
  • Less weight loss than injectable at approved doses
  • Higher-dose versions (25–50 mg) in trials; may close gap with injectable
Full Rybelsus guide →

Side-by-Side Comparison

FeatureOzempicWegovyMounjaroRybelsus
Drug classGLP-1 agonistGLP-1 agonistGIP + GLP-1 agonistGLP-1 agonist
AdministrationWeekly injectionWeekly injectionWeekly injectionDaily tablet
Health Canada approved forType 2 diabetesWeight managementType 2 diabetesType 2 diabetes
Average weight loss~9–13%~15%~15–21%~4–5%
Monthly cost (no insurance)$200–$450$385–$430$400–$620+$200–$350
Generic available?Yes (2025)Yes (2025)NoNo
Provincial formulary (diabetes)Most provincesN/ALimitedSeveral provinces
Off-label weight managementCommonN/A (on-label)CommonSome use
Titration period4–12 weeks16–20 weeks8–20 weeks4–8 weeks
GI side effectsCommon (mild)Common (mild)Common (mild)Common (mild-mod)

Which Should You Choose?

1

If:

I have type 2 diabetes and want public coverage

Ozempic (via ODB or provincial plan)

Covered in most provinces with LU code. Most cost-effective option if you qualify.

2

If:

I want maximum weight loss and cost is secondary

Mounjaro 15 mg

Highest average weight loss in clinical trials (~21%). Most expensive and no generic yet.

3

If:

I want the best weight loss at the most accessible price

Wegovy or generic semaglutide

Wegovy has a formal weight-management approval. Generic semaglutide (arriving 2025-26) will be dramatically cheaper.

4

If:

I have needle phobia and prefer a pill

Rybelsus

Only approved oral GLP-1. Less weight loss than injectables at current doses, but next-generation higher doses may close the gap.

Head-to-Head Comparisons

Deep-dive articles comparing two medications at a time - efficacy, cost, side effects, and who each is best suited for.

Province Guides

Coverage criteria, drug plan details, and access options for each province.

Not available in Quebec or Canadian territories. A licensed provider will confirm eligibility after your assessment.